Back to results
US 2013/0295564 A1Published application
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
AssigneesSequenom Center for Molecular Medicine, Sequenom, Inc.
InventorsMathias EHRICH, Anders Olof Herman NYGREN, Tyler Jacob JENSEN
Life of this patent
Estimating the term…
Abstract
Provided are compositions and processes that utilize genomic regions that are differentially methylated between a mother and her fetus to separate, isolate or enrich fetal nucleic acid from a maternal sample. The compositions and processes described herein are particularly useful for non-invasive prenatal diagnostics, including the detection of chromosomal aneuploidies.
Claims19
A method for determining the amount of fetal nucleic acid in a sample comprising:
- a) contacting nucleic acid from a pregnant female, which nucleic acid comprises fetal nucleic acid and maternal nucleic acid, the combination of the fetal nucleic acid and the maternal nucleic acid comprising total nucleic acid in the sample, with a methylation sensitive restriction enzyme that specifically digests the maternal nucleic acid at a plurality of loci, wherein the plurality of loci comprises:
- i) loci that are hypermethylated in fetal nucleic acid;
- and
- ii) one or more loci selected from loci of SEQ ID NOs:90-163, 176, 179, 180, 184, 188, 189, 190, 191, 193, 195, 198, 199, 200, 201, 202, 203, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 221, 223, 225, 226, 231, 232, 233, 235, 239, 241, 257, 258, 259, and 261, thereby enriching the fetal nucleic acid;
- b) determining the amount of fetal nucleic acid in the sample.
2 more elements
Dependencies are inferred from the claim text.